Catalyst Wire Dossier Catalyst Wire Dossier

Autologous CAR-T/TCR-T cell therapy (investigational)

· Shenzhen BinDeBio Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CAR-T/TCR-T cell therapy (investigational), covering 2021-02-04 to 2021-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]

See pricing